Trial: 201405089

Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

Phase

II/III

Principal Investigator

Adkins, Douglas

Disease Site

Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov